EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 4th, 2026 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 4th, 2026 Company Industry JurisdictionThis Executive Employment Agreement (this “Agreement”) is made by and between Odyssey Therapeutics, Inc., a Delaware corporation (the “Company”, and together with any parent company, any and all direct or indirect subsidiaries of the Company, and their affiliates, in each case, existing now or in the future, “Odyssey”), and Gary D. Glick (the “Executive”), and shall become effective as of, and conditional upon, the day prior to the Public Trading Date (as defined below) (such date, the “Effective Date”).
FORM OF EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 4th, 2026 • Odyssey Therapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 4th, 2026 Company Industry JurisdictionThis Executive Employment Agreement (this “Agreement”) is made by and between Odyssey Therapeutics, Inc., a Delaware corporation (the “Company”, and together with any parent company, any and all direct or indirect subsidiaries of the Company, and their affiliates, in each case, existing now or in the future, “Odyssey”), and [●] (the “Executive”), and shall become effective as of, and conditional upon, the day prior to the Public Trading Date (as defined below) (such date, the “Effective Date”).